AV
ADPT icon

Alamea Verwaltungs’s Adaptive Biotechnologies ADPT Stock Holding History

Alamea Verwaltungs’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Buy
24,124
+7,094
+42% +$109K 0.41% 55
2026
Q1 		$236K Hold
17,030
– – 0.18% 79
2025
Q4 		$315K Buy
+17,030
New +$278K 0.21% 78

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Alamea Verwaltungs's ADPT Position: Q2 2026 in Review

Alamea Verwaltungs increased its Adaptive Biotechnologies (ADPT) stake by 42% in Q2 2026, buying an estimated $109K and bringing the position to 24,124 shares worth $517K. The position accounts for 0.41% of the portfolio, ranked #55.

Alamea Verwaltungs first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Alamea Verwaltungs held 24,124 shares of Adaptive Biotechnologies worth $517K as of Q2 2026.
  • Alamea Verwaltungs bought 7,094 Adaptive Biotechnologies shares in Q2 2026, an estimated $109K.
  • Adaptive Biotechnologies made up 0.41% of Alamea Verwaltungs's portfolio in Q2 2026, its #55 holding.
  • Alamea Verwaltungs first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Alamea Verwaltungs's 13F filing for Q2 2026, filed 13 Aug 2026.